1612-1615 (1997).
2. Cao, Z., et al., Science, 271, 1128-1131 (1996).
3. Huang, J., et al., Proc. Natl. Acad. Sci. USA, 94,
12829-12832 (1997).
4. Croston, G. E., et al., J. Biol. Chem., 270, 16514-
1612-1615 (1997).
2. Cao, Z., et al., Science, 271, 1128-1131 (1996).
3. Huang, J., et al., Proc. Natl. Acad. Sci. USA, 94,
12829-12832 (1997).
4. Croston, G. E., et al., J. Biol. Chem., 270, 16514-
, Mol. Microbiol., 86(5),
1116-1131 (2012).
7. Bandy, N. J. et al., J. Bacteriol., 196(13),
2396-2404 (2014).
8. Rascón-Castelo, E. et al., Vaccines, 3(4),
973-987 (2015).
9. Maema
Biophys. Acta, 1131,
333-336 (1992).
2. Matter, K., and Hauri, H. P., Biochemistry, 30,
1916-1923 (1991).
3. Wilhelm, A., et al., J. Biol. Chem., 279,
43330-43335 (2004).
4. Matter, K., and
sequence with a three-tyrosine motif
corresponding to Tyr 1158, 1162 and 1163 (for the IR)
and Tyr 1131, 1135 and 1136 (for the IGF-1R). It is
generally believed that autophosphorylation within the
activation
P. Q., Spauwen, P. H. & Jansen, J. A. (2005)
Biomaterials 26, 1131–1138.
15. Parikh, S. N. (2002) J. Postgrad. Med. 48, 142–148.
16. Mistry, A. S. & Mikos, A. G. (2005) Adv. Biochem. Eng. Biotechnol
at the second tyrosine (1162 or 1135),
followed by phosphorylation at the first tyrosine (1158
or 1131), then the last (1163 or 1136), upon which the
IR or IGF-1R becomes fully active.
at the second tyrosine (1162 or 1135),
followed by phosphorylation at the first tyrosine (1158
or 1131), then the last (1163 or 1136), upon which the
IR or IGF-1R becomes fully active.
3050 Spruce
lipoprotein3 binding sites on human blood monocytes using
fluorescence-labeled ligand. J. Lipid Res. 40, 1131-1139 (1999)
6. Lloyd-Evans, P., et al., Use of a phycoerythrin-conjugated anti-
glycophorin A monoclonal
polycations: influence of polymer
structure on cell viability and hemolysis. Biomaterials 24(7),
1121–1131 (2003).
37 Persson I, Lindman B. Flocculation of Cell Debris for Improved
Separation by Centrifugation